Open AccessNovel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma
Author(s) -
Angela Mweempwa,
Huiling Xu,
Joseph H.A. Vissers,
Richard W. Tothill,
Andrew Pattison,
Andrew Fellowes,
David M. Thomas,
Gary Richardson,
Rodney J. Hicks,
Sean M. Grimmond,
Stephen B. Fox,
Stephen J. Luen,
Jayesh Desai,
Benjamin Solomon
Publication year - 2021
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
ISSN - 2473-4284
DOI - 10.1200/po.21.00127
Subject(s) - pheochromocytoma , cancer research , proto oncogene proteins c ret , medicine , fusion , chemistry , oncology , philosophy , receptor , linguistics , glial cell line derived neurotrophic factor , neurotrophic factors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom